Immunocore Holdings plc (IMCR)
Immunocore Holdings plc, a biotechnology firm established in 1999 and based in Abingdon, United Kingdom, has reached the commercial stage in its mission to create pioneering immunotherapies. The company's development pipeline addresses a range of serious conditions, including various cancers, infectious diseases, and autoimmune disorders. Its currently marketed product, KIMMTRAK, offers a treatment option for patients with uveal melanoma that is either unresectable or has metastasized. Within oncology, Immunocore is progressing IMC-C103C through early-stage (Phase I/II) dose escalation trials for several solid tumor types, notably non-small-cell lung (NSCLC), gastric, head and neck, ovarian, and synovial sarcoma cancers. Another key oncology program, IMC-F106C, is also in Phase I/II dose escalation studies for a diverse array of solid malignancies, including NSCLC, small-cell lung, endometrial, ovarian, cutaneous melanoma, and breast cancers. For infectious diseases, the company is advancing IMC-I109V in Phase I/II clinical trials for chronic hepatitis B virus, alongside IMC-M113V, which is undergoing preclinical development for human immunodeficiency virus (HIV). Additionally, Immunocore is developing novel therapeutic candidates designed to deliver precise, targeted immunosuppression as a treatment strategy for autoimmune conditions.
Sector: Biological Products, (No Diagnostic Substances)
Industry: Biotechnology
Immunocore Holdings plc
No splits on record
Nothing in IMCR's public trading history: no forward or reverse split has affected the share count.
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | GBP | GBP | GBP | GBP | GBP | GBP | GBP | GBP | GBP | GBP | GBP |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-09-30 | 2013-09-30 |
| Revenue | $297.57M | $247.98M | $197.39M | $144.23M | $27.04M | $30.11M | $25.67M | $23.65M | $14.45M | $16.46M | $11.46M | $6.38M | $2.04M |
| YoY Growth | 20.0% | 25.6% | 36.9% | 433.3% | -10.2% | 17.3% | 8.5% | 63.7% | -12.2% | 43.7% | 79.6% | 211.9% | - |
| Cost of Revenue | $6.21M | $5.54M | $821K | $5.29M | $0 | $74.81M | $99.99M | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $291.36M | $242.44M | $196.57M | $138.94M | $27.04M | -$44.7M | -$74.32M | $23.65M | $14.45M | $16.46M | $11.46M | $6.38M | $2.04M |
| Gross Margin | 97.9% | 97.8% | 99.6% | 96.3% | 100.0% | -148.4% | -289.5% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Research and Development | $204.47M | $177.44M | $129.42M | $84.31M | $74.31M | $74.81M | $99.99M | $83.58M | $61.16M | $46.01M | $22.13M | $12.2M | $6.54M |
| Selling, General, and Administrative | $120.62M | $121.17M | $114.35M | $0 | $82.15M | $45.74M | $44.18M | $34.16M | $22.03M | $3.75M | $2.99M | $2.47M | $1.17M |
| Other | $0 | $152K | $0 | $97.4M | $0 | -$79.05M | -$100.18M | $0 | -$310K | -$824K | $0 | -$989K | -$867K |
| Total Operating Expenses | $325.09M | $298.77M | $243.77M | $181.71M | $156.46M | $41.5M | $44M | $117.73M | $82.87M | $48.94M | $25.11M | $13.69M | $6.84M |
| Operating Income (EBIT) | -$33.74M | -$56.28M | -$47.2M | -$42.77M | -$129.42M | -$86.19M | -$118.32M | -$93.45M | -$67.53M | -$32.48M | -$13.65M | -$7.31M | -$4.79M |
| Operating Margin | -11.3% | -22.7% | -23.9% | -29.7% | -478.5% | -286.2% | -460.9% | -395.1% | -467.4% | -197.3% | -119.2% | -114.6% | -234.3% |
| Interest Expense | $12.17M | $18.84M | $4.08M | $5.41M | $5.57M | $3.11M | $3.8M | $842K | $0 | $0 | $0 | $0 | $0 |
| Interest Income | $16.48M | $25.62M | $14.23M | $3.76M | $65K | $706K | $1.4M | $822K | $0 | $0 | $0 | $0 | $26K |
| Other Income (Expense) | $19.53M | $14.01M | -$982K | $8.95M | -$3.92M | -$1.17M | $36.65M | $5.28M | $2.79M | $1.27M | $28.07M | $122K | $26K |
| Income Before Tax (EBT) | -$14.21M | -$42.32M | -$48.19M | -$33.82M | -$133.34M | -$87.36M | -$81.67M | -$88.18M | -$64.73M | -$31.21M | $14.41M | -$7.19M | -$4.77M |
| Income Tax Expense | $12.21M | -$1.48M | -$4.43M | $9.65M | $111K | -$13.27M | $22.26M | -$16.55M | $15.81M | $8.08M | $960K | $1.59M | $1.07M |
| Net Income | -$26.42M | -$40.81M | -$43.75M | -$43.46M | -$133.45M | -$74.09M | -$103.93M | -$71.63M | -$49.57M | -$23.13M | $13.45M | -$5.59M | -$3.69M |
| Net Income Margin | -8.9% | -16.5% | -22.2% | -30.1% | -493.4% | -246.0% | -404.9% | -302.8% | -343.1% | -140.5% | 117.4% | -87.7% | -180.6% |
| Supplementary Data | |||||||||||||
| EPS | -0.53 | -1.02 | -0.89 | -0.95 | -3.13 | -2.33 | -3.81 | -2.62 | -20.16 | -9.45 | 0.00 | -2.53 | 0.00 |
| Diluted EPS | -0.53 | -1.02 | -0.89 | -0.95 | -3.00 | -2.33 | -3.81 | -2.62 | -20.16 | -9.45 | 0.00 | -2.53 | 0.00 |
| Weighted Average OS | 50.35M | 49.99M | 48.89M | 45.71M | 42.49M | 31.78M | 27.31M | 27.31M | 2.46M | 2.45M | 0 | 2.21M | 0 |
| EBITDA | $387K | -$37.66M | -$40.87M | -$38.37M | -$123.71M | -$79.59M | -$108.96M | -$86.75M | -$64.33M | -$29.7M | -$11.16M | -$6.6M | -$4.36M |
| EBITDA Margin | 0.1% | -15.2% | -20.7% | -26.6% | -457.4% | -264.3% | -424.5% | -366.7% | -445.3% | -180.4% | -97.4% | -103.4% | -213.2% |
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | GBP | GBP | GBP | GBP | GBP | GBP | GBP | GBP | GBP | GBP | GBP |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-09-30 | 2013-09-30 |
| Assets | |||||||||||||
| Current Assets | |||||||||||||
| Cash and Cash Equivalents | $467.71M | $455.73M | $350.27M | $402.47M | $321.06M | $176.78M | $97.99M | $124.39M | $83.99M | $134.29M | $219.98M | $50.84M | $16.32M |
| Short-Term Investments | $396.44M | $364.64M | $0 | $0 | $0 | $0 | $0 | $0 | $34.55M | $42.22M | $0 | $0 | $0 |
| Cash and Short-Term Investments | $864.15M | $820.38M | $350.27M | $402.47M | $321.06M | $176.78M | $97.99M | $124.39M | $118.54M | $176.51M | $219.98M | $50.84M | $16.32M |
| Accounts Receivable | $73.98M | $83.1M | $48.62M | $57.08M | $33.52M | $2.05M | $66.3M | $4.37M | $4K | $430K | $186K | $203K | $307K |
| Inventory | $6.74M | $5.45M | $3.56M | $692K | $0 | -$6.51M | $0 | -$7.57M | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $51.87M | $7.9M | $7.68M | $3.62M | -$7.69M | -$25.9M | $352K | $42.42M | $18.14M | $10.6M | $6.55M | $2.35M | $1.41M |
| Total Current Assets | $996.74M | $929.86M | $418.48M | $473.98M | $354.58M | $152.93M | $164.64M | $171.18M | $145.37M | $191.09M | $228.96M | $54.24M | $18.04M |
| Long-Term Assets | |||||||||||||
| Property, Plant & Equipment Net | $50.24M | $47.73M | $33.82M | $38.78M | $42.56M | $36.85M | $72.7M | $20.87M | $24.24M | $11.06M | $7.81M | $2.65M | $1.29M |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $410 | $0 | $0 | $0 | $318K | $743K | $372K | $142K | $207K | $258K |
| Long-Term Investments | $0 | $0 | $0 | $137K | $223K | $973K | $0 | $0 | $0 | $14.76M | $36.62M | $3.78M | $65 |
| Deferred Tax Assets | $0 | $14.79M | $8.68M | $5.12M | $3.48M | $2.23M | $2M | $872K | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $20.28M | $17.12M | $11.45M | $8.75M | $6.44M | $4.21M | $6.6M | $2.53M | $27.69M | $1.8M | $0 | $0 | $0 |
| Total Long-Term Assets | $70.53M | $79.64M | $53.96M | $52.78M | $52.7M | $44.26M | $81.3M | $24.6M | $52.67M | $27.99M | $44.57M | $6.63M | $1.54M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $1.07B | $1.01B | $472.44M | $526.76M | $407.28M | $197.19M | $245.94M | $195.78M | $198.04M | $219.08M | $273.53M | $60.87M | $19.58M |
| Liabilities | |||||||||||||
| Current Liabilities | |||||||||||||
| Accounts Payable | $24.36M | $25.1M | $14.08M | $14.45M | $10.12M | $7.88M | $20.84M | $6.44M | $8.15M | $3.11M | $3.62M | $825K | $566K |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $9.84M | $27.96M | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $1.43M | $1.12M | $718K | $620K | $95K | $779K | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $583K | $0 | $0 | $7.76M | $33M | $27.12M | $37.78M | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $16.54M | $13.1M | $9.18M | $9.15M | $84K | -$19.8M | $25.28M | $29.91M | $15.66M | $13.46M | $299K | $158K | $8.44M |
| Total Current Liabilities | $246.7M | $212.18M | $110.01M | $100.83M | $82.57M | $55M | $111.96M | $49.61M | $30.15M | $21.8M | $22.63M | $18.6M | $8.44M |
| Long-Term Liabilities | |||||||||||||
| Long-Term Debt | $393.13M | $391.01M | $37.99M | $47.81M | $50.24M | $36.65M | $0 | $18.88M | $17.17M | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $4.86M | $5.43M | $4.36M | $5.24M | $8.65M | $24.87M | $63.54M | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | -$24.87M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $774K | $2.21M | $77K | $25.01M | $139K | $70.71M | $13.17M | $22.29M | $36.41M | $44.37M | $0 |
| Total Long-Term Liabilities | $439.54M | $436.61M | $70.54M | $87.02M | $93.19M | $86.85M | $114.41M | $89.59M | $30.34M | $22.29M | $36.41M | $44.37M | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $686.24M | $648.79M | $180.55M | $187.86M | $175.76M | $141.85M | $226.37M | $139.19M | $60.49M | $44.1M | $59.04M | $62.98M | $8.44M |
| Stockholders' Equity | |||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $136K | $135K | $83K | $129K | $119K | $64K | $0 | $0 | $0 | $0 | $0 | $2K | $2K |
| Retained Earnings | -$831.27M | -$795.76M | -$589.3M | -$689.39M | -$649.7M | -$349.87M | -$369.75M | -$175.18M | -$111.48M | -$61.07M | -$11M | -$27.77M | -$22.2M |
| Comprehensive Income & Other | -$28.08M | -$33.76M | -$28.7M | -$54.67M | $521.31M | $405.15M | $14.08M | $67K | $22.06M | $12.72M | $1.9M | $69K | $0 |
| Other Stockholders' Equity | $1.21B | $1.16B | $881.1M | $1.03B | $881.11M | $405.15M | $389.31M | $231.76M | $249.03M | $236.06M | $225.49M | $25.66M | $25.2M |
| Total Equity | $381.03M | $360.72M | $291.89M | $338.9M | $231.53M | $55.35M | $19.57M | $56.58M | $137.55M | $174.98M | $214.5M | -$2.1M | $3M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $1.07B | $1.01B | $472.44M | $526.76M | $407.28M | $197.19M | $245.94M | $195.78M | $198.04M | $219.08M | $273.53M | $60.87M | $11.44M |
| Supplementary Data | |||||||||||||
| Total Debt | $436.69M | $432.72M | $66.5M | $81.45M | $86.16M | $74.47M | $78.7M | $18.88M | $17.17M | $0 | $0 | $0 | $0 |
| Net Debt | -$31.02M | -$23.01M | -$283.77M | -$321.02M | -$234.9M | -$102.31M | -$19.29M | -$105.51M | -$66.82M | -$134.29M | -$219.98M | -$50.84M | -$16.32M |
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | GBP | GBP | GBP | GBP | GBP | GBP | GBP | GBP | GBP | GBP | GBP |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-09-30 | 2013-09-30 |
| Operating Activities | |||||||||||||
| Net Income | -$26.42M | -$51.09M | -$34.32M | -$52.54M | -$180.03M | -$74.09M | -$103.93M | -$71.63M | -$49.57M | -$23.13M | $13.45M | -$5.59M | -$3.69M |
| Depreciation & Amortization | $2.43M | $4.2M | $3.24M | $4.39M | $5.5M | $9.23M | $9.36M | $6.71M | $4.1M | $2.78M | $1.36M | $714K | $432K |
| Deferred Income Tax | $11M | $0 | $0 | -$3.53M | -$12.69M | -$13.27M | -$22.26M | -$16.55M | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $0 | $34.19M | $25.69M | $32.89M | $48.89M | $8.16M | $3.06M | $666K | $3.26M | $1.68M | $1.48M | $65K | $4K |
| Changes in Working Capital: | |||||||||||||
| Accounts Receivable | -$5.46M | -$12.35M | -$14.14M | -$26.26M | -$4.86M | -$532K | $1.83M | $0 | -$6.5M | -$1.69M | -$1.69M | -$1.15M | -$58K |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | -$1.83M | $7.27M | $2.08M | $4.91M | $1.47M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Working Capital | $366K | $50.2M | $16.64M | -$2.81M | -$18.57M | -$28.27M | -$11.92M | $67.58M | -$10.15M | -$1.8M | $0 | $0 | $0 |
| Total Working Capital Change | -$6.92M | $45.13M | $4.58M | -$24.16M | -$21.96M | -$28.8M | -$10.09M | $67.58M | -$16.65M | -$3.49M | -$1.69M | -$1.15M | -$58K |
| Other Non-Cash Items | $11.94M | -$6.38M | $3.14M | -$6.25M | $17.19M | $38.19M | $22.49M | -$3.4M | -$2.87M | -$14.74M | -$32.52M | $45.76M | $14.58M |
| Net Cash from Operating | -$7.97M | $26.06M | $2.33M | -$49.21M | -$143.11M | -$60.57M | -$101.38M | -$16.63M | -$61.73M | -$36.9M | -$17.92M | $39.79M | $11.26M |
| Investing Activities | |||||||||||||
| Capital Expenditures | -$3.23M | -$5.17M | -$3.37M | -$2.2M | -$1.39M | -$3.07M | -$4.28M | -$3.54M | -$17.73M | -$6.18M | -$5.79M | -$2.03M | -$579K |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | -$22.32M | -$350M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $13.39M | $0 | $0 | $0 | $0 | $0 | $0 | $27.45M | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $44K | -$925K | $6K | $106K | $3.54M | $139K | $34.1M | $7.99M | $35.6M | $596K | -$3.65M | $104K |
| Net Cash from Investing | -$12.16M | -$355.13M | -$4.29M | -$2.2M | -$1.28M | $467K | -$4.14M | $58.01M | -$9.74M | $29.42M | -$5.2M | -$5.68M | -$475K |
| Financing Activities | |||||||||||||
| Debt Repaid | - | -$352.5M | - | - | - | -$45.13M | $4.04M | - | -$18.77M | - | - | - | - |
| Common Stock Issuance | $9.2M | $6.8M | $0 | $139.51M | $286.89M | $113.41M | $59.87M | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | -$15.42M | $27.18M | $5.93M | $1.3M | -$42.6M | -$711K | $101K | $561K | $96K | $158.36M | $404K | $3M |
| Net Cash from Financing | $9.2M | $343.88M | $27.18M | $145.44M | $288.19M | $115.94M | $55.13M | $101K | $19.33M | $96K | $158.36M | $404K | $3M |
| Forex Effect | $19.81M | -$1.71M | $6.56M | -$12.65M | $625K | -$84K | -$33K | $13K | -$10K | $11K | $0 | $0 | $207K |
| Net Change in Cash | $8.89M | $13.11M | $31.78M | $81.39M | $144.42M | $55.75M | -$50.42M | $41.5M | -$52.15M | $134.29M | $0 | $50.84M | $16.32M |
| Supplementary Data | |||||||||||||
| Operating Cash Flow | -$7.97M | $26.06M | $2.33M | -$49.21M | -$143.11M | -$60.57M | -$101.38M | -$16.63M | -$61.73M | -$36.9M | -$17.92M | $39.79M | $11.26M |
| Capital Expenditure | -$3.23M | -$5.17M | -$4.29M | -$2.2M | -$1.39M | -$3.07M | -$4.28M | -$3.54M | -$17.73M | -$6.18M | -$5.79M | -$2.03M | -$579K |
| Free Cash Flow | -$11.2M | $20.89M | -$1.97M | -$51.41M | -$144.49M | -$63.65M | -$105.65M | -$20.16M | -$79.46M | -$43.08M | -$23.71M | $37.76M | $10.69M |
| Cash at Beginning | $338.23M | $442.63M | $318.5M | $321.08M | $176.66M | $73.97M | $124.39M | $82.88M | $136.14M | $0 | $0 | $0 | $0 |
| Cash at End | $347.11M | $455.73M | $350.27M | $402.47M | $321.08M | $129.72M | $73.97M | $124.39M | $83.99M | $134.29M | $0 | $50.84M | $16.32M |